Many Brits might unknowingly be walking a knife’s edge with their health, as an expert warned if left untreated, the disease ...

Crisugabalin provides significant improvement in average daily pain score and shows promise as a postherpetic neuralgia treatment.

Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

The Phase III trial AV001 aims to evaluate QUTENZA in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures ...

Between 10-18% of those who get shingles develop post-herpetic neuralgia (PHN), a condition marked by debilitating nerve pain lasting over six months and often beyond one year. There is no approved ...

Jiangsu Alicorn Pharmaceutical Co. Ltd. has described AP2-associated protein kinase 1 (AAK1) inhibitors reported to be useful for the treatment of Alzheimer’s disease, bipolar disorder, Parkinson’s ...

In March 2023, my 94-year-old mother had a shingles episode on the right side of her neck, head, ear and (to a lesser degree) ...

and I have read estimates that somewhere between 13% to 30% of people over 80 with shingles will develop PHN. Now that she’s ...

and I have read estimates that somewhere between 13% to 30% of people over 80 with shingles will develop PHN. Now that she’s ...